The Contribution of LATE‐NC to Neuropsychiatric Symptom Burden in Alzheimer's Disease and Lewy Body Disease: A Clinicopathological Study

LATE-NC对阿尔茨海默病和路易体病神经精神症状负担的贡献:一项临床病理学研究

阅读:2

Abstract

BACKGROUND: Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological change (LATE‐NC) frequently coexists with Alzheimer's disease (AD), Lewy body disease (LBD), and vascular pathology. While neuropsychiatric symptoms in AD/LATE‐NC are beginning to be explored, the impact of LATE‐NC in mixed AD/LBD and LBD is still underexamined. This study investigated neuropsychiatric symptom profiles in individuals with AD, LBD, and mixed AD/LBD with and without LATE‐NC. METHOD: In this retrospective cohort study, individuals from the UBC Hospital Clinic for Alzheimer's and Related Disorders (UBCH‐CARD) autopsy database with AD, LBD or both plus LATE‐NC pathology (LATE+, n = 42) were matched by age and neuropathology to controls without LATE‐NC (LATE‐, n = 38). Neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory Questionnaire (NPI‐Q) at initial, intermediate, and final visits before death. Outcomes included symptom severity scores at the final visit, odds ratios of symptoms at the final visit and trajectories of symptom progression. Parametric and non‐parametric tests were used to compare symptom severity scores, while linear mixed‐effects models analyzed longitudinal symptom data, adjusting for age, sex, education, and Clinical Dementia Rating Scale (CDR). RESULT: Mean age at death was 80.5 years (LATE+) and 77.9 years (LATE‐), and participants were followed on average 5.8 years. Both groups had a high burden of moderate‐to‐severe AD pathology (LATE+ 97.6% vs. LATE‐ 94.4%) and moderate numbers had neocortical LBD (31.7% vs. 41.7%, p = 0.50). At the final visit, total NPI‐Q severity scores were similar between groups (5.65 vs. 6.12, p = 0.71). Symptom severity scores for apathy (0.73 vs. 1.29, p = 0.01), hallucinations (0.24 vs. 0.82, p = 0.01), and appetite changes (0.08 vs. 0.41, p = 0.04) were lower in LATE+. Odds ratios for symptom presence at the final visit, adjusted for coexisting pathology, remained significant for hallucinations only (0.013, 95% CI 0.001‐0.218, p = 0.002). Longitudinal modeling showed no significant differences in total burden of neuropsychiatric symptoms. CONCLUSION: LATE‐NC did not appear to increase overall neuropsychiatric symptom burden in this autopsy cohort study of individuals with AD and/or LBD. Hallucinations were less frequent in the LATE+ group, but this may be due to incomplete adjustment for coexisting Lewy Body pathology. Further modelling of longitudinal symptom progression will be presented at the conference.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。